Status:
COMPLETED
Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Atrius Health
National Institutes of Health (NIH)
Conditions:
Aging
Benzodiazepine Sedative Adverse Reaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines and sedative hypnotics are, for example, key drug classes frequently implicated in adverse health co...
Detailed Description
This is an adaptive cluster randomized control trial (RCT) to evaluate whether newly designed EHR-based tools designed using behavioral principles reduce inappropriate prescribing and adverse outcomes...
Eligibility Criteria
Inclusion
- Primary care provider at Atrius Health
- Providers will receive these EHR tools for their patients who meet the following criteria:
- older adults (aged 65 years or more)
- who have been prescribed at least 90 pills of benzodiazepine or sedative hypnotic in the last 180 days.
Exclusion
- NA
Key Trial Info
Start Date :
October 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04284553
Start Date
October 13 2020
End Date
August 31 2022
Last Update
November 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atrius Health
Braintree, Massachusetts, United States, 02184